Rural Versus Urban Genitourinary Cancer Incidence and Mortality in Pennsylvania: 1990-2019.

IF 2.8 4区医学 Q2 ONCOLOGY

Current oncology Pub Date : 2024-12-23 DOI:10.3390/curroncol31120597

Jonathan Pham, Ahmad N Alzubaidi, Jay D Raman, Tullika Garg

{"title":"Rural Versus Urban Genitourinary Cancer Incidence and Mortality in Pennsylvania: 1990-2019.","authors":"Jonathan Pham, Ahmad N Alzubaidi, Jay D Raman, Tullika Garg","doi":"10.3390/curroncol31120597","DOIUrl":null,"url":null,"abstract":"Our aim was to describe the incidence and mortality of genitourinary (GU) cancers in rural and urban Pennsylvania counties. We calculated age-adjusted incidence and mortality rates of GU (prostate, bladder, and kidney) cancers from 1990 to 2019 in the Pennsylvania Cancer Registry. We defined rurality using the Center for Rural Pennsylvania's population density-based definition. We modeled average annual percent changes (AAPC) in age-adjusted incidence and mortality rates using joinpoint regression. Overall GU cancer incidence decreased in rural and urban counties (AAPC -7.5%, p = 0.04 and AAPC -6.6%, p = 0.02, respectively). Prostate cancer incidence decreased in rural and urban counties by -10.5% (p = 0.02) and -9.1% (p = 0.01), respectively. Kidney cancer incidence increased in both rural and urban counties, respectively (AAPC = +11.2, p = 0.002 and +9.3%, p = 0.01). GU cancer mortality decreased in rural and urban counties (AAPC = -11.6, p = 0.047 and AAPC -12.2, p = 0.01, respectively). Prostate cancer mortality decreased at similar rates in rural and urban counties (AAPC -15.5, p = 0.03 and -15.4, p = 0.02, respectively). Kidney cancer mortality decreased in urban (AAPC -6.9% p = 0.03) but remained stable in rural counties. Bladder cancer incidence and mortality were unchanged in both types of counties. Over three decades, GU cancer incidence and mortality decreased across Pennsylvania counties.","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":"31 12","pages":"8110-8117"},"PeriodicalIF":2.8000,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11674802/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/curroncol31120597","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Our aim was to describe the incidence and mortality of genitourinary (GU) cancers in rural and urban Pennsylvania counties. We calculated age-adjusted incidence and mortality rates of GU (prostate, bladder, and kidney) cancers from 1990 to 2019 in the Pennsylvania Cancer Registry. We defined rurality using the Center for Rural Pennsylvania's population density-based definition. We modeled average annual percent changes (AAPC) in age-adjusted incidence and mortality rates using joinpoint regression. Overall GU cancer incidence decreased in rural and urban counties (AAPC -7.5%, p = 0.04 and AAPC -6.6%, p = 0.02, respectively). Prostate cancer incidence decreased in rural and urban counties by -10.5% (p = 0.02) and -9.1% (p = 0.01), respectively. Kidney cancer incidence increased in both rural and urban counties, respectively (AAPC = +11.2, p = 0.002 and +9.3%, p = 0.01). GU cancer mortality decreased in rural and urban counties (AAPC = -11.6, p = 0.047 and AAPC -12.2, p = 0.01, respectively). Prostate cancer mortality decreased at similar rates in rural and urban counties (AAPC -15.5, p = 0.03 and -15.4, p = 0.02, respectively). Kidney cancer mortality decreased in urban (AAPC -6.9% p = 0.03) but remained stable in rural counties. Bladder cancer incidence and mortality were unchanged in both types of counties. Over three decades, GU cancer incidence and mortality decreased across Pennsylvania counties.

查看原文本刊更多论文

宾夕法尼亚州农村与城市泌尿生殖系统癌发病率和死亡率：1990-2019。

我们的目的是描述宾夕法尼亚州农村和城市县泌尿生殖系统（GU）癌症的发病率和死亡率。我们计算了宾夕法尼亚州癌症登记处1990年至2019年GU（前列腺癌、膀胱癌和肾癌）的年龄调整发病率和死亡率。我们使用宾夕法尼亚农村中心基于人口密度的定义来定义乡村。我们使用结合点回归对年龄调整后发病率和死亡率的年均百分比变化（AAPC）进行建模。农村和城市县的总体GU发病率下降（AAPC分别为-7.5%,p = 0.04和-6.6%,p = 0.02）。农村和城市县前列腺癌发病率分别下降-10.5% （p = 0.02）和-9.1% （p = 0.01）。农村和城市县的肾癌发病率分别上升（AAPC = +11.2, p = 0.002和+9.3%,p = 0.01）。农村县和城市县的胃癌死亡率下降（AAPC = -11.6, p = 0.047, AAPC -12.2, p = 0.01）。在农村和城市县，前列腺癌死亡率下降的速度相似（AAPC分别为-15.5,p = 0.03和-15.4,p = 0.02）。城市地区肾癌死亡率下降（AAPC -6.9% p = 0.03），但农村地区保持稳定。膀胱癌的发病率和死亡率在两种类型的县没有变化。在过去的30年里，宾州各县的胃癌发病率和死亡率都有所下降。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current oncology ONCOLOGY-

CiteScore

3.30

自引率

7.70%

发文量

664

审稿时长

1 months

期刊介绍： Current Oncology is a peer-reviewed, Canadian-based and internationally respected journal. Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy in Canada to report upon and to review progress in the management of this disease. We encourage submissions from all fields of cancer medicine, including radiation oncology, surgical oncology, medical oncology, pediatric oncology, pathology, and cancer rehabilitation and survivorship. Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine.